Our vision is to be the catalyst for groundbreaking advancements in drug development.
By harnessing the power of artificial intelligence we are creating innovative solutions that drive unprecedented efficiency, accessibility, and patient-centricity throughout the drug development process.
Our team of industry experts and technology pioneers are dedicated to accelerating the path from discovery to delivery. We empower pharmaceutical companies, research organizations, and patients to collaborate like never before, unlocking new possibilities in the pursuit of life-changing therapies.
Our proprietary AI solutions are leading the transformation of the pharmaceutical industry. We envision a future where cutting-edge treatments are brought to market swiftly, with precision and affordability. Our virtual patient models predict study outcomes and optimize every step of the clinical trial journey.
Our vision is to be the catalyst for groundbreaking advancements in drug development.
Powerhouse Front Bench.
20+ years of experience in Healthcare and life sciences.
Launched more than 35 products globally, across a variety of TA’s, including but not limited to Oncology, Neurology, Rare Disease and others.
Worked with PwC, CVS Health, BioSolutia/Caremetx, Parexel, Amgen and others.
Numerous Technology Implementation/ Digital Transformation, Operational Efficiency, and Innovative Product Development and Utilization.
Strategic Advisor – client advocate and relationship builder
Life sciences executive with over 22 years expertise in data analytics, RWD/RWE, clinical research, market access, leadership and strategic partnerships.
Proven success driving business opportunities, managing key alliances, and exceeding sales and growth targets.
Core strengths in clinical research, commercialization, real-world data/evidence, AI, business development, strategic planning, and sales cycle and pipeline management.
Chief Data Officer – in-house geek and technology maven
Executive Advisor l Information & Decision Scientist l Operations Management
Worked on over 100 new projects with entrepreneurs and companies across the globe in numerous industries, including manufacturing, health and medical, telecommunications, information technology.
Academic rank of Professor in the Managerial Economics & Decision Sciences and Operations Management department.
Executive advisor and Chief Learning Officer
Executive Advisor SFU Venture Labs, startup coach, Chief Learning Officer (CLO) and former IBM Executive, Chief Operating Officer, Associate Faculty member, and TED Talker, constantly looking for ways to accelerate opportunity.
Chuck focuses on Learning Strategies, AI, Blockchain, Web3, and Digital Transformation.
More than 30 years of R&D leadership across the pharmaceutical and biotechnology industries.
Has previously served as Head of R&D IT/CIO for MedImmune, AstraZeneca’s biologics division, and later led Data Science and AI for AstraZeneca.
Has held senior roles at Schrödinger, Accelrys, GlaxoSmithKline, and Merck & Co. His career began with undergraduate research at Penn State, followed by roles at Tektagen (Charles River Laboratories), the Pennsylvania State Police as a forensic scientist, and STC (Orasure) as an R&D scientist. He holds degrees in biochemistry and molecular biology from Pennsylvania State University and Lehigh University.
Clinical Development executive with 20+ years experience spanning AbbVie, Labcorp Drug Development, Covance, emerging biotechs, specialty CROs, and MedTech innovators. Proven track record advising organizations on clinical trial strategy, operational transformation, and healthcare innovation. Proven track record supporting the successful development and approval of six therapies and medical technologies.
Core expertise in AI-enabled clinical development, neurosciences, immunology, oncology, radiopharmaceuticals, feasibility intelligence, clinical operations, portfolio strategy, MedTech, and growth strategy.
Jeffrey Scott Yablon is a life sciences executive with more than 25 years of experience driving growth, strategic partnerships, and clinical development solutions across biotech, pharma, and CRO organizations. He has held senior leadership roles with TAP Pharmaceuticals, Icon PLC, Parexel, Cognizant Life Sciences, ArisGlobal, Frontage Laboratories and Jigsaw Clinical Research, where he served as President and CEO . Jeffrey now serves as a Champion for Luminari, helping organizations accelerate innovation through AI enabled clinical and regulatory intelligence.
